The Hidden Danger of Environmental Chemicals during the “Windows of Susceptibility” in a Woman’s Life – How can we use Intermediate Biomarkers to Improve Breast Cancer Prevention?

1. INTRODUCTION

Despite enormous progress in the field of Breast Cancer (BC) research, primary and secondary prevention of BC still remains very challenging [1]. This is mostly due to the fact that several known risk factors for BC have only modest correlations with the BC prevalence [1]. This is opposite to some other common malignancies (e.g., cervical or lung cancer), which are strongly connected to certain predominant risk factors, such as human papillomavirus, in the case of cervical cancer, or tobacco smoking in the case of lung cancer [2, 3]. In addition, numerous BC risk factors are often inconvenient or difficult to address via public health interventions.

Furthermore, traditional models of BC causation were usually based on exploring just one BC risk factor or BC cause at a time. However, several such factors typically interact with each other, and thus, their combination can lead to BC [4]. Therefore, it is becoming obvious that the transdisciplinary research on the impact of the environmental exposures on BC etiology is of utmost importance [4].

In fact, for many women, different risk factors for BC may still remain controversial or insufficient as targets for effective BC prevention [1]. At this point, longitudinal epidemiological studies can shed new light on the idea that toxic chemical exposures during some specific periods in a women’s life maybe crucial to the subsequent BC risk or development [5]. These so-called windows of susceptibility (WOS), involving the prenatal, pubertal, pregnancy, and menopausal transition periods, correspond with certain “mile-stones,” during which the mammary glands undergo anatomical and functional transformations [5]. In fact, when various toxic agents, derived from the environment (e.g., endocrine-disrupting chemicals (EDC)), and certain therapeutics (e.g., prescribed for the coexisting medical conditions or in the form of the hormone replacement therapy) act upon breast tissue during the particular WOS, they can influence BC risk, development, or outcome (Fig. 1) [5, 6].

In this paper, the evidence derived from epidemiologic studies focusing on the connections between environmental toxic chemical agents and BC within four critical WOS has been outlined. In addition, this mini-review provides some directions for ongoing and further research on intermediate biomarkers for BC. Moreover, the article describes an interdis- ciplinary research model, which combines input from the biological, behavioral, social, and physical domains that can serve as a useful tool for the exploration of environmental causes and risk factors, which can contribute to BC.

2. LOOKING FOR IMPORTANT NON-GENETIC RISK FACTORS AND CAUSES OF BC

Since “anything that is not genetic” can be considered as “environmental,” including many toxic agents, such as EDC, the relations between common chemical compounds and the risk or incidence of BC (or some intermediate outcomes related to BC, like age at onset of menarche) have revealed some important information [7]. EDC have been found in many industrial and agricultural chemical agents, as well as in numerous commercial and personal care products [7].

The most dangerous EDC include the following: organochlorines (e.g., Polychlorinated Biphenyls (PCBs) and dioxins), pesticides (e.g., Dichlorodiphenyltrichloroethane (DDT)), organohalogenated compounds (e.g., Polybrominated Diphenyl Ethers (PBDE)), per-and Poly-fluoroalkyl Substances (PFAS), Perfluorooctanoic Acid (PFOA), Phenols (e.g., Bisphenol A (BPA)), phthalates, parabens, Polycyclic Aroma- tic Hydrocarbons (PAH), benzene, ethylene oxide, certain metals (e.g., cadmium), and Dimethylbenz [a]Anthracene (DMBA) [6].

Furthermore, it should be noted that the excessive body mass, usually related to multiple reasons (e.g., elevated energy intake, poor quality of food, sedentary lifestyle, and decreased energy expenditure), and in particular, an increased body fat content, often share some BC risk factors with the environmental exposures [8]. An anthropometric parameter, such as the body mass index (BMI) (e.g., above 25, defined as overweight, and above 30, defined as obesity) has been associated with an increased risk of postmenopausal BC, a decreased risk of premenopausal BC, and an earlier age at menarche [9]. However, BMI is not the most accurate biomarker to evaluate body fat content. In fact, abdominal (central) fat is metabolically important with regard to insulin resistance and potential malignancy risk.

The paradoxical relationship of obesity (e.g., BMI above 30) in pre- versus post-menopausal women can be partially explained by the differential frequency of Estrogen Receptor-positive/Progestin Receptor positive (ER+/PR+) tumors, which can occur in these two age groups [10]. The ER+/PR+ tumors, which are more frequent among postmenopausal women, are more sensitive to Estrogen (E) that can be produced by the adipose tissue. In contrast, the ER−/PR− tumors are more common in the premenopausal population, and thus, such tumors can be due to some other risk factors (e.g., unrelated to the endocrine system). In addition, adipose tissue can serve as a reservoir for EDC, which is lipophilic and can be stored in the body for prolonged periods of time [11, 12].

3. ENDOCRINE AND CHEMICAL ENVIRONMENTAL INLUENCES ON BC RISK AND DEVELOPMENT, DURING THE SPECIFIC WINDOWS OF SUSCEPTIBILITY (WOS)

The four WOS are concisely presented in Table 1, including brief characteristics of physiological changes that typically occur in the breast tissue and the descriptions of potential harmful effects of EDC, which can take place during these critical periods [13, 14]. It should be noted that pregnancy may have a dual effect on BC risk. On the one hand, it has been known that a full-term pregnancy decreases the BC risk. On the other hand, however, some recent studies have reported that while the full-term pregnancy indeed lowers the risk for ER+ and luminal BC, pregnancy can also augment the risk of a very aggressive, basal-like BC subtype [15].

Based on preclinical studies, this can be related to the fact that the protective endocrine pathways may disturb by prolonged exposure to exogenous 17β-estradiol, which restores sensitivity to carcinogen-induced mammary tumors [16]. Since multiple complex interrelationships exist between age, ethnicity, parity, and body size (e.g., obesity), it is very difficult to clearly interpret and translate such data into the community audience (e.g., patients with BC, their families, and involved medical personnel). At this point, it should be highlighted that the tumor heterogeneity, especially in the case of the basal-like BC subtype, as well as the dynamic changes in the tumor microenvironment, promoting the development of basal-like BC during the post-partum period, plays important roles in this situation [15]. Furthermore, it has been known that both early pregnancy and multi-parity can decrease the risk of BC later in a woman’s life (e.g., post-menopause). In this context, the differentiation of the breast tissue caused by the physiological hormonal changes during pregnancy (e.g., increased progesterone level) has been considered to be protective against BC. Some complex mechanisms of the pregnancy impacting BC risk and development have been studied by investigating environmental chemicals (e.g., phenols), which were found in higher levels among pregnant females [17]. It is conceivable that such toxic agents may deteriorate the natural, protective pathways related to breast tissue rearrangement during pregnancy.

Some exemplary studies exploring correlations between the risk of BC and toxic chemical exposures from the envir- onment during particular WOS are summarized in Table 2. Notably, a prospective Child Health and Development Study (CHDS) is a landmark study connecting toxic environmental exposures during pregnancy and the future risk of BC [14]. In the CHDS, the DDT levels were measured in mothers soon after pregnancy, and then, these DDT levels were linked with the subsequent BC diagnoses established in their daughters (based on the documentation from medical records) [14].

Since BC is often hormonally stimulated, the physiological decline of female sex hormones, due to the decreased ovarian production, explains the reduction of the age-specific BC among post-menopausal women [18]. However, many BC cases are diagnosed after menopause, partially due to the augmented ER sensitivity at the time of menopausal transition. In addition, findings from the Women’s Health Initiative (WHI) study have revealed a higher incidence of BC, especially during the first year of hormonal therapy (HT) [19, 20].

In addition to chemical toxins, some metals, which activate the ERs, also known as metalloestrogens, represent as widely spread environmental contaminants that can accumulate in human tissues and organs [21]. With regard to BC, many studies have been focused on cadmium, which induces the proliferation of E-dependent BC cells, augments the transcription and expression of E-regulated genes, activates ERα, and increases cellular signaling via the ERK1/2 and AKT pathways [22, 23]. It is conceivable that the exposure to cadmium or other metalloestrogens, during any of the four WOS, may impact the BC risk via abnormal mitogenic signaling or inducing DNA synthesis in the BC cells [22, 24]. However, further studies investigating whether or not the exposures to certain metals or EDC during the particular WOS are related to BC risk are definitely merited, as well as exploring potential mechanisms of such correlations.

4. EXPLORING LONG LATENCY OF ENVIRONMENTAL CONTAMINANTS – IMPLICATIONS FOR USING NEW BIOMARKERS IN BC RESEARCH

The prolonged latency periods, from harmful exposures (during the prenatal, puberty, pregnancy, and menopausal transition WOS) to the BC occurrence, represent serious obstacles to introducing effective strategies for BC prevention. Unfortunately, many environmental toxins are lipophilic, and thus, they can be deposited in the adipose tissue reservoir (e.g., in the breast) for a long time [25]. It should be underscored that even though manufacturing of several dioxins, PCBs, and pesticides (e.g., DDT) was formally terminated in the 1970s, there might have been some exposures to such harmful agents due to their prolonged bioaccumulation in the animal’s adipose tissues, causing subsequent food contamination (Table 1) [25].

Processes of bioaccumulation of toxic agents and products of their metabolism in human tissues require further research, with the application of reliable biomarkers, which will reflect possible adverse changes in epithelial, adipose, and stromal tissue of the breast. In addition, it needs to be underscored that since the environmental chemicals can impact the onset and duration of the puberty or menopausal transition, research involving intermediate biomarkers (e.g., mammographic breast density (MBD)) should provide reliable information. Simply put, MBD presents the proportion of connective and glandular tissue to adipose tissue on a mammogram, and thus, it may serve as an intermediate outcome measure or possible marker or predictor of BC risk [26]. In fact, such parameters may even be more valuable than a girl’s age at menarche or a woman’s age at the beginning of menopause. Moreover, since many years could have elapsed from the toxic exposures to the establishing of BC diagnosis, the incorporation of MBD is crucial, particularly in prospective clinical studies.

One of the important diagnostic problems among women younger than 40 years is related to the fact that the information pertinent to the normal breast tissue appearance has been derived from mammography data of females over 40 years of age. Therefore, for a more accurate diagnostic work-up, in women younger than 40 years, different imaging methods should be applied to precisely evaluate the breast composition [27]. For instance, Magnetic Resonance Imaging (MRI) should be used for females 15–30 years old [28, 29] and Dual X-ray Absorptiometry (DXA) for girls 10 -16 years old [30]. Also, it should be noted that Optical Spectroscopy (OS), which displays a structure of the breast, reflecting its composition (e.g., the amount of water, hemoglobin, adipose, collagen, cellular and connective tissue density), can be very useful [31, 32]. In particular, collagen density can influence epithelial cell proliferation and enhance tumor invasion, while hemoglobin may affect angiogenesis [33, 34]. For instance, OS has been applied to non-invasively evaluate differences in adolescent breast tissue in different developmental Tanner stages during puberty [35]. In this way, MRI, DXA, and OS can serve as innovative, intermediate biomarkers to measure breast tissue changes during the developmental transformations in adole- scence or early adulthood. Moreover, these tests help overcome the inconvenience of long latency intervals of various EDC. They may also serve as valid tools for exploring EDC environmental influences during the breast developmental phases. In addition, some modern mammography techniques, such as digital breast tomosynthesis, as well as ultrasono- graphy, have been helpful in examining breast density in younger women without harmful exposure to radiation [27].

5. BRIDGING THE GAP BETWEEN THE NEEDS OF PATIENTS WITH BC IN THE COMMUNITY AND THE CURRENT BC ENVIROMENTAL RESEARCH

Unquestionably, community involvement can facilitate the implementation of BC research findings into daily practice. However, to determine the particular knowledge gaps and speed-up dissemination of the results of environmental BC studies, coordinated with particular WOS, it is essential to integrate efforts of the basic, clinical, public health, and communication research experts together with the medical providers and their patients with BC, or women at risk for BC, in the community. Such liaisons will be crucial since both the causes and the solutions for common toxic environmental exposures remain outside of the clinical settings.

At this point, an adequate community input may quickly detect problems, which pose particular concerns to several women at risk for BC. Moreover, a translation of new research data to the community members should enable a lot of patients with BC (or their female relatives at risk for it) to make informed decisions about their medical care, safe workplace, homestead or neighborhood, and healthy lifestyle. It should be highlighted that the personal involvement of many women with BC in the community partnerships has helped them learn about specific environmental hazards to their health and timely introduce the necessary modifications [36]. It should be highlighted that since many women are being diagnosed with BC above the age of 60 years, the effective prevention of EDC environmental exposures should be started in the early WOS. This requires new, proactive approaches to the patient’s education as well as the engagement in their own healthcare. Simultaneously, empowering physicians to spare no effort to prevent BC across generations in close cooperation with well-informed and motivated patients poses another big challenge [37].

6. PARADIGM II - AS A HELPFUL MODEL REFLECTING THE COMPLEXITY OF CAUSES AND RISK FACTORS FOR BC

In response to this challenge, the current model of the causes and risk factors for BC, Paradigm II, combines the complex interconnections between numerous components originating from four basic domains: biological, behavioral, social, and physical (relevant to the environment), which contribute to BC. In essence, Paradigm II reflects 96 potential dynamic interactions between these four domains [38]. Paradigm II was designed by a multidisciplinary team of experts of epidemiology, cancer biology, genetics, toxicology, public health, biostatistics, and computational modeling [38]. Although Paradigm II does not directly serve to diagnose and treat patients, it should be very useful for physicians and nurses as a modern educational tool for patients with BC, their family members, and caregivers. Its particular strength is related to the fact that it simultaneously focuses on the multiple interrelated causes and risk factors for BC that can be understandable and meaningful for many patients suffering from BC (e.g., family/genetic predispositions, exposure to toxic/carcinogenic chemicals at the workplace/house, and second-hand smoke) (Fig. 1) [5, 6, 38].

Furthermore, the Paradigm II convincingly summarizes the updated knowledge about the relationships between various modifiable factors, which can be controlled or eliminated by individual women (e.g., tobacco smoking, alcohol consump- tion, and excessive intake of fatty, sweet, or highly processed food, lack of regular exercises, hormone replacement therapy, and use of toxic personal care products). In addition, some specific spheres of public health, which are related to social, economic, and industrial factors, which can have a profound adverse impact on women’s health, have been outlined. Hopefully, such a comprehensive and persuasive model will encourage both women with BC (or at risk for it) and medical teams in charge of their care to be actively involved in the preventive and therapeutic processes, utilizing intermediate biomarkers. Moreover, Paradigm II should inspire further research projects since it interactively presents the ever-changing relationships and often surprising manners by which the various causes and risk factors for BC can interact together and affect each other, depending on the changing circum- stances, during lifespans of individual women.

CONCLUSION

The biological alterations in breast tissue structure and endocrine signaling during the prenatal, pubertal, pregnancy, and menopausal transition WOS reflect the elevated BC risk at these particular periods. Therefore, measuring the effects of toxic environmental exposures during the four WOS is crucial to understand their impact on further BC risk and development. Notably, some epidemiologic studies have shown a connection between human exposure to toxic chemical agents, during critical WOS, via the application of intermediate biomarkers (e.g., MBD, especially in adolescent and young adult patients).

An integrative model of BC research is crucial to determine the influence and mechanisms of action of various EDC during critical periods in a woman’s lifespan. Hopefully, detecting the exact biological role of various EDC (originating from certain environmental exposures) at the specific WOS will contribute to measurable progress in BC prevention and therapeutic management of many women with BC or at risk for it.

For the most accurate exploration of several interconnected environmental causes of BC, an interdisciplinary BC research model, Paradigm II, combining input from the epidemiology, basic, and communication sciences, should be instrumental. Consequently, a close collaboration between researchers, medical practitioners, patients with BC, and the local community representatives is necessary. In this way, the newest research results in this area, applying intermediate biomarkers, would have a chance to be rapidly disseminated to the medical teams and the most vulnerable patients with BC, or women at risk for it, as well as their families or caregivers.

REFERENCES